BIOTECH
BIOTECH
STALICLA and Firefly Neuroscience enter Partnership Agreement for the Development of Electroencephalogram (EEG) as a Biomarker for Subgroups of Patients with ASD
STALICLA and Firefly Neuroscience enterPartnership Agreement for the Development of Electroencephalogram (EEG) asa Biomarker for Subgroups of Patients with...
Read more
BIOTECH
Jaguar Health Announces Initial Close in Private Placement Financing Round for Napo Therapeutics S.p.A.
This closing on funds from SPRIM Global Investments, a healthcare-focused international venture capital firm, was...
Read more
BIOTECH
Spexis and SPRIM Global Investments (SGI) Announce Plans for Clinical Trial Partnership to Fund up to Half of the Projected Phase 3 Clinical Development Costs of ColiFin®
Ad hoc announcement pursuant to Art. 53 LR SGI debt facility to provide Spexis up...
Read more
BIOTECH
STALICLA signs exclusive in-licensing agreement for late-stage clinical neuropsychiatric and neurodevelopmental disorder treatment
STALICLA signs exclusive in-licensing agreement for late-stage clinical neuropsychiatric and neurodevelopmental disorder treatment The transaction with Novartis reinforces STALICLA’s position as the leading developer of precision...
Read more
BIOTECH
AUM Biosciences, a Global Biotechnology Company Developing Precision Oncology Therapeutics, Announces Plans to Become a Public Company via Merger with Mountain Crest Acquisition Corp. V
The transaction reflects a pre-money equity value of $400 million for AUM Biosciences Transaction is...
Read more